2023.11.09
Reprolife made a significant mark at the American Society for Reproductive Medicine (ASRM) 2023 conference in New Orleans, where we showcased the innovative Cryotec Ready to Use oocyte and embryo vitrification product series.
Revolutionizing Vitrification with Ready to Use
The Cryotec Ready to Use series was introduced with a focus on simplicity, efficiency, and unparalleled attention to detail. This improved method, developed by Dr. Masashige Kuwayama, promises a seamless experience for embryologists, making it not only user-friendly but also a time-saving solution for embryologists.
Hands-On Experience at ASRM Workshops
Reprolife didn’t just unveil their revolutionary product; we also provided embryologists with a hands-on experience through workshops at ASRM. The response was overwhelmingly positive, with participants praising the simplicity and effectiveness of the Ready to Use series.
Embryologists’ Feedback: A Resounding Success
Participants at the workshops shared their enthusiasm for Ready to Use. The product’s ease of use, time-saving attributes, and design precision left a lasting impression on embryologists from the USA and various other countries.
Looking Ahead
While the Ready to Use series is making waves in the reproductive technology landscape, it’s important to note that it is not yet FDA approved and is currently available only in certain countries. Reprolife, however, remains committed to advancing reproductive technologies and looks forward to making our products available in more countries soon.
For more information about RtU or other Cryotec products, please contact us
